2.59  0.16 (6.58%)		09-14 16:00
Open: 2.48 High: 2.665 Volume: 101,661		Pre. Close: 2.43 Low: 2.38 Market Cap: 3(M)

Short term
Mid term
Targets	6-month :	21.49	1-year :	33.07
Resists	First :	18.39	Second :	28.31
Pivot price	3.18
Supports	First :	2.34	Second :	1.95
MAs	MA(5) :	2.57	MA(20) :	5.31
	MA(100) :	20.62	MA(250) :	607.37
MACD	MACD :	-1.5	Signal :	-1.4
%K %D	K(14,3) :	3.3	D(3) :	1.7
RSI	RSI(14): 43.1
52-week	High :	3000	Low :	2.34

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ PFSA ] has closed above bottom band by 32.2%. Bollinger Bands are 84.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	2.67 - 2.68	2.68 - 2.69
Low:	2.35 - 2.37	2.37 - 2.38
Close:	2.57 - 2.59	2.59 - 2.61

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Fri, 04 Sep 2026
Profusa (PFSA) CEO restructures 334K-share holding - Stock Titan

Fri, 04 Sep 2026
Profusa (PFSA) CFO shifts stake from sponsor to direct - Stock Titan

Wed, 19 Aug 2026
Profusa (PFSA) sponsor’s $1.3M debt swap nears half the stock - Stock Titan

Wed, 19 Aug 2026
Profusa (PFSA) CEO turns $1.29M note into 301,991 shares - Stock Titan

Sat, 15 Aug 2026
HRT Financial sells $2,211 in Profusa (PFSA) shares By Investing.com - Investing.com Nigeria

Fri, 14 Aug 2026
Profusa (PFSA) 10% owner HRT FINANCIAL reports net sale of 36,826 shares - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	1 (M)
Shares Float	0 (M)
Held by Insiders	27.5 (%)
Held by Institutions	3.4 (%)
Shares Short	11 (K)
Shares Short P.Month	13 (K)

EPS	-922.06
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-205.03
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-725.3 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-20 (M)
Levered Free Cash Flow	-19 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	-0.02
Price to Sales	0
Price to Cash Flow	-0.08

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.